Skip to main content

Web Exclusives

Acute Lymphoblastic Leukemia

Roles and Responsibilities of the Multidisciplinary Care Team in Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Transition of Care for Patients with Acute Lymphoblastic Leukemia

Gastrointestinal Cancers

Nivolumab Demonstrates Significant Overall Survival Benefits in Patients with Previously Treated Esophageal Squamous-Cell Carcinoma Compared with Chemotherapy

Gastrointestinal Cancers

Trifluridine/Tipiracil and Ramucirumab Demonstrate Antitumor Activity in Previously Treated Unresectable Advanced Gastric or Gastroesophageal Cancer

Gastrointestinal Cancers

Insertion-Deletion Rate Is Associated with Clinical Outcomes in Nivolumab-Treated Gastric Cancer

Gastrointestinal Cancers

Surufatinib in Combination with Toripalimab Demonstrates Antitumor Responses in Previously Treated Patients with Gastric or Gastroesophageal Adenocarcinoma

Gastrointestinal Cancers

Analysis of PD-L1 Expression by Combined Positive Score May Help Identify Which Patients with Advanced Gastric/Gastroesophageal Junction Cancer Will Respond to Treatment with Nivolumab and Ipilimumab

Gastrointestinal Cancers

Ramucirumab plus Paclitaxel Confers an Overall Survival Advantage Over Placebo in the RAINBOW-Asia Study

Gastrointestinal Cancers

Zolbetuximab in Combination with Epirubicin/Oxaliplatin/Capecitabine Shows Survival Advantage in Patients with Gastric, Gastroesophageal Junction, and Esophageal Cancer: The FAST Study

Gastrointestinal Cancers

Second-Line Nivolumab with Paclitaxel plus Ramucirumab Shows Promising Antitumor Responses in Patients with Advanced Gastric Cancer

Page 3 of 43
Results 21 - 30 of 425